Arantxa Tabernero

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea Álvarez-Vázquez, Laura San-Segundo, Pilar Cerveró-García, Raquel Flores Hernández, Claudia Ollauri-Ibáñez, Berta Segura-Collar, Christopher G Hubert, Gillian Morrison, Steven M Pollard, Justin D Lathia, Vicente A Torres, Arantxa Tabernero
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models. Neuro-oncology 26 (7) (2024)
Andrea Álvarez-Vázquez, Laura San-Segundo, Pilar Cerveró-García, Raquel Flores Hernández, Claudia Ollauri-Ibáñez, Berta Segura-Collar, Christopher G Hubert, Gillian Morrison, Steven M Pollard, Justin D Lathia, Vicente A Torres, Arantxa Tabernero
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models. Neuro-oncology 26 (7) (2024)
Andrea Álvarez-Vázquez, Laura San-Segundo, Pilar Cerveró-García, Raquel Flores Hernández, Claudia Ollauri-Ibáñez, Berta Segura-Collar, C G Hubert, Gillian Morrison, Steven M Pollard, Justin D Lathia, Vicente A Torres, Arantxa Tabernero
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models. Neuro-oncology (2024)
Andrea Álvarez-Vázquez, Laura San-Segundo, Pilar Cerveró-García, Raquel Flores Hernández, Claudia Ollauri-Ibáñez, Berta Segura-Collar, Christopher G Hubert, Gillian Morrison, Steven M Pollard, Justin D Lathia, Vicente A Torres, Arantxa Tabernero
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models. Neuro-oncology 26 (7) (2024)
Andrea Álvarez-Vázquez, Laura San-Segundo, Pilar Cerveró-García, Raquel Flores Hernández, Claudia Ollauri-Ibáñez, Berta Segura-Collar, Christopher G Hubert, Gillian Morrison, Steven M Pollard, Justin D Lathia, Vicente A Torres, Arantxa Tabernero
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models. Neuro-oncology 26 (7) (2024)
Sara G Pelaz, Arantxa Tabernero
Src: coordinating metabolism in cancer. Oncogene 41 (45) (2022)
Sara G Pelaz, Claudia Ollauri-Ibáñez, Concepción Lillo, Arantxa Tabernero
Impairment of Autophagic Flux Participates in the Antitumor Effects of TAT-Cx43266-283 in Glioblastoma Stem Cells. Cancers 13 (17) (2021)
Rocío Talaverón, Esperanza R Matarredona, Alejandro Herrera, José M Medina, Arantxa Tabernero
Connexin43 Region 266-283, via Src Inhibition, Reduces Neural Progenitor Cell Proliferation Promoted by EGF and FGF-2 and Increases Astrocytic Differentiation. International journal of molecular sciences 21 (22) (2020)
Trond Aasen, Edward Leithe, Sheila V Graham, Petra Kameritsch, María D Mayán, Marc Mesnil, Kristin Pogoda, Arantxa Tabernero
Connexins in cancer: bridging the gap to the clinic. Oncogene 38 (23) (2019)